Atarax Drops (Hydroxyzine)
| Active Ingredient (Generic Name): | Hydroxyzine |
| Manufacturer: | Dr Reddy’s Laboratories Ltd |
| Packaging: | 15 ml in 1 bottle |
| Strength: | 6 mg |
| Delivery Time: | 6 To 15 days |
| SKU: | Atarax Drops (Hydroxyzine) |
Product details
| Quantity |
3 Bottle/s ,6 Bottle/s ,12 Bottle/s |
|---|
Description
Customer Reviews
Rated 0 out of 5
0 reviews
Rated 5 out of 5
0
Rated 4 out of 5
0
Rated 3 out of 5
0
Rated 2 out of 5
0
Rated 1 out of 5
0
Be the first to review “Atarax Drops (Hydroxyzine)” Cancel reply
Related Products
Select options
This product has multiple variants. The options may be chosen on the product page
Select options
This product has multiple variants. The options may be chosen on the product page
Select options
This product has multiple variants. The options may be chosen on the product page
Admenta 5 mg (Memantine)
$69.00 – $189.00Price range: $69.00 through $189.00
Select options
This product has multiple variants. The options may be chosen on the product page
Atarax 10 mg (Hydroxyzine)
$135.00 – $252.00Price range: $135.00 through $252.00
Select options
This product has multiple variants. The options may be chosen on the product page
Atarax 50 mg (Hydroxyzine)
$311.00 – $603.00Price range: $311.00 through $603.00
Select options
This product has multiple variants. The options may be chosen on the product page
Atarax 25 mg (Hydroxyzine)
$266.00 – $513.00Price range: $266.00 through $513.00
Select options
This product has multiple variants. The options may be chosen on the product page
Select options
This product has multiple variants. The options may be chosen on the product page
Flunil 20 mg (Fluoxetine)
$90.00 – $336.00Price range: $90.00 through $336.00
Select options
This product has multiple variants. The options may be chosen on the product page
Venlor-XR 37.5mg (Venlafaxine)
$75.00 – $300.00Price range: $75.00 through $300.00
Select options
This product has multiple variants. The options may be chosen on the product page

Reviews
Clear filtersThere are no reviews yet.